Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194255 | SCV000247199 | uncertain significance | not specified | 2014-10-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000194255 | SCV000721356 | likely benign | not specified | 2017-07-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000868554 | SCV001009895 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408856 | SCV002715318 | likely benign | Inborn genetic diseases | 2019-02-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003736629 | SCV004564727 | likely benign | not provided | 2023-03-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955149 | SCV004778331 | likely benign | DYNC1H1-related condition | 2024-01-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |